ABX

ANALYST NOTE: ABX (Abacus Global Management, Inc.) Date: 2026-06-13

(1) Structural Readiness The setup is a confirmed coil with a breakout fired. The conservative entry level is $10.75. The current price is $10.71, representing an extension of -0.4% relative to the conservative entry. The ATR at the time of the breakout was 4.3% (High bucket), and the current ATR remains 4.3% (High bucket). This volatility profile indicates a structural quality consistent with the historical "sweet spot" for active setups. The setup is actionable; the base has formed and the breakout signal has been triggered.

(2) The Thesis Layer As of this date, ABX is classified as a TACTICAL, setup-led name. There is no named secular thesis attached to this specific setup in the current evidence base. The conviction for this position must be derived strictly from the quality of the technical setup (the confirmed coil) and the immediate business fundamentals disclosed in recent filings and earnings calls, rather than a broader macroeconomic or industry-wide secular trend.

(3) The Business Abacus Global Management operates as an alternative asset manager and market maker in the life settlements industry, purchasing life insurance policies from individuals or institutions, bundling them into tranches, and selling them to investors, insurance carriers, or funds.

• Scale & Market Position: As of the end of 2025, the company reported Assets Under Management (AUM) of approximately $3.33 billion. The company holds an estimated 26% market share based on capital invested relative to the total industry capital invested.
• Operational Velocity: In Q1 2026 alone, the company reviewed nearly 9,000 qualified policies, a significant increase from roughly 11,000 policies reviewed across the entirety of 2025. During this same quarter, the company deployed $163.6 million in capital off its balance sheet.
• Capital Efficiency & Funding: The company successfully executed a $50 million investment-grade securitized note in October 2025, establishing a repeatable, lower-cost funding mechanism. Following the success of this first securitization, management stated they are actively targeting a second significant securitization in late Q2 or early Q3 2026.
• Profitability & Margins: The average realized gain per policy sold improved to 26.4% for the three months ended March 31, 2026, up from 21.0% in the prior year period.
• Guidance: In the May 7, 2026 earnings transcript, management raised full-year 2026 adjusted net income guidance to a range of $100 million to $106 million (up from $96M–$104M) and expects Q2 2026 adjusted net income of $24 million to $26 million ($0.24–$0.26 EPS).
• Diversification: The company operates in 49 states and has purchased over $10 billion in face value of life insurance policies since 2004.

(4) The Archetype and Conviction ABX fits the Growth Leader archetype. This classification is supported by the company's inclusion on TIME magazine's inaugural "World's Growth Leaders of 2026" list and its demonstrated ability to scale operations (reviewing 9,000 policies in one quarter) while improving margins (26.4% realized gain).

• Valuation Context: The financial spine indicates a forward consensus EPS of $1.00 for FY1 and $1.15 for FY2.
• Conviction Stack:
• Thesis Strength: Moderate (Tactical/Setup-led, no macro thesis).
• Evidence Quality: High (Recent earnings beat, raised guidance, specific operational metrics).
• Structural Quality: High (Confirmed coil, High ATR bucket).
• Rerating Potential: Supported by the successful securitization model and the launch of the LifeARC AI platform (announced June 10, 2026), which aims to enhance lifespan modeling and operational efficiency.
• ATR Context: The 4.3% ATR (High bucket) suggests the stock is in a healthy volatility range for a growth leader, neither too stagnant nor excessively erratic.

(5) Invalidations, Strengtheners, and Gaps

• What would Strengthen the Case: Successful execution of the second securitization target (late Q2/early Q3); continued expansion of the LifeARC platform adoption; further margin expansion in policy acquisitions.
• What would Invalidate the Case: A failure to execute the targeted second securitization; a significant deterioration in the realized gain per policy; a material adverse ruling in the ongoing defamation suit against Coventry (noted as advancing in court as of June 26, 2026).
• Gaps in Evidence: While the company is named a "Growth Leader," specific long-term secular thesis data points (e.g., multi-year CAGR projections for the specific AI segment) are not explicitly detailed in the provided evidence beyond the TIME award and the platform launch announcement. The impact of the defamation suit on long-term capital raising is not yet quantified in the financials.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Confirmed coil breakout with high ATR structural quality; raised full-year 2026 net income guidance to $100M-$106M; successful $50M securitization establishing repeatable funding. Key risks: Ongoing defamation litigation with Coventry; execution risk on the targeted second securitization; concentration risk with two related-party customers accounting for 27% of revenue. Rating boundary: This is rated Buy rather than Strong Buy because the setup is tactical and setup-led without a named secular thesis, and the litigation risk introduces a specific binary event that prevents a higher conviction rating. It is rated Buy rather than Speculative because the fundamental evidence (raised guidance, margin expansion, AUM growth) is robust and the technical setup is confirmed, not merely forming. Sizing hint: Position size should reflect the high ATR volatility and the binary nature of the litigation outcome, utilizing the 4.3% ATR for standard risk sizing. Expected path: Management expects to close the second securitization in late Q2 or early Q3, which should lower the cost of capital and support further capital deployment into policy acquisitions. Expected horizon: 3 to 6 months for the second securitization to close and for the market to price in the Q2 earnings guidance. Failure mode to watch: The second securitization fails to materialize or the defamation suit results in a material adverse judgment that restricts capital access.